Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection

NCT00147381 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

197

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Alemtuzumab
DRUG: Tacrolimus
DRUG: Alemtuzumab

Sponsor

Dr. Claudia Bösmüller

Collaborators

[object Object]